Interferential therapy: a new treatment for slow transit constipation. A pilot study in adults.
Summary of "Interferential therapy: a new treatment for slow transit constipation. A pilot study in adults."
Aim:â€‚ The study aimed to assess, for the first time, the effectiveness of Interferential Therapy (IFT) in the treatment of slow-transit constipation in adults and its impact on the quality of life. Method:â€‚ All consecutive patients with slow-transit constipation diagnosed by symptomology and a colonic transit time (CTT) of >100 hours (h) measured with radiopaque markers were included in this prospective study. IFT was performed for 1 hour per day over 3 months. Clinical improvement was based on the stool diary and the KESS and Cleveland Clinic Constipation scores. Quality of life was assessed with the GIQLI questionnaire. Results:â€‚ Eleven patients with a median age of 51 years were included. At the end of the follow-up period, 7 (63.6%) had significantly improved after IFT with a median of 0.66 stools per week (IQR, 0.33-0.66) before treatment and 1.66 (IQR, 1.33-1.66) after (p=0.007). The KESS score rose from 30 (IQR, 27-33) before treatment to 19 (IQR, 17-26) after treatment (15-33) (p=0.005) and the Cleveland Clinic Constipation Score from 26 (IQR, 25-28) to 17 (IQR, 13-24) (p=0.005). The CTT improved from 103 (IQR, 101-113) to 98 (IQR, 94-107) (p=0.02) h. The GIQLI score improved from 60 (IQR, 57-63) to 95 (IQR, 68-100) (p=0.005). Conclusion:â€‚ Interferential therapy is a new, non-invasive treatment for slow transit constipation. Further studies to confirm these results with longer follow-up are necessary. Â© 2012 The Authors Colorectal Disease Â© 2012 The Association of Coloproctology of Great Britain and Ireland.
Service de colo-proctologie, Clinique des cĂ¨dres, Cornebarrieu Service de gastroentĂ©rologie, CHU Nord, Marseille Interface de recherche translationnelle en neurogastroentĂ©rologie, CRN2M, UMR 7286, Aix-Marseille UniversitĂ©, Marseille UnitĂ© de recherch
This article was published in the following journal.
Name: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
Constipation is an extremely common problem in children, varying from mild and short-lived to severe and chronic. Chronic constipation is a serious childhood condition and requires further investigati...
Slow transit constipation (STC) is associated with colonic motor abnormalities. The underlying cause(s) of the abnormalities remain poorly defined. In health, utilizing high resolution fiber-optic man...
Chronic constipation is a very common disease in children. Successful treatment of constipation can be achieved not only with medication but also with lifestyle changes, including a proper diet. Diets...
In-transit melanoma is an uncommon pattern of recurrence, but presents unique management challenges and opportunities for treatment. The clinical presentation usually involves from 1 to more than 100 ...
Studies with other imaging modalities have demonstrated a relationship between contrast transit and cardiac output (CO) and pulmonary vascular resistance (PVR). We tested the hypothesis that the trans...
Functional constipation is a common problem in Hong Kong. In a recent telephone survey, the prevalence of constipation as defined by Rome II criteria was 14%. Apart from organic, metabolic...
The purpose of this study is to evaluate the synergism of Soluble Dietary Fiber with Fecal Microbiota Transplantation in Adult Patients with Slow Transit Constipation.
Chronic constipation is a strong public health problem. Its prevalence is about 15% in Western countries with a significant impact on quality of life and health care costs . Two subtypes o...
The study hypothesis is that the naturally occurring bile acid, chenodeoxycholic acid, induces acceleration of colonic transit in health and in patients with constipation-predominant IBS
This study will evaluate the effects of tegaserod on orocecal and colonic transit in patients over 65 years with chronic constipation.
Medical and Biotech [MESH] Definitions
Small-scale tests of methods and procedures to be used on a larger scale if the pilot study demonstrates that these methods and procedures can work.
Preliminary cancer therapy (chemotherapy, radiation therapy, hormone/endocrine therapy, immunotherapy, hyperthermia, etc.) that precedes a necessary second modality of treatment.
Drug therapy given to augment or stimulate some other form of treatment such as surgery or radiation therapy. Adjuvant chemotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment.
A diphenylmethane stimulant laxative used for the treatment of constipation and for bowel evacuation. (From Martindale, The Extra Pharmacopoeia, 30th ed, p871)
The use of art as an adjunctive therapy in the treatment of neurological, mental, or behavioral disorders.